Asymptomatic often sent for lung cancer screening tests

March 13, 2012
Asymptomatic often sent for lung cancer screening tests

(HealthDay) -- A majority of primary care physicians report ordering lung cancer screening tests for asymptomatic patients, according to research published in the March/April issue of the Annals of Family Medicine.

Using questionnaires completed by 962 family physicians, general practitioners, and , Carrie N. Klabunde, Ph.D., of the in Bethesda, Md., and associates assessed primary care physicians' knowledge of guidelines, beliefs about screening, and ordering of tests. Intentions to screen asymptomatic 50-year-old patients with varying smoking histories for the disease were assessed by use of clinical vignettes.

The researchers found that, during 2006 to 2007, 38 percent ordered no lung cancer screening tests, and 55, 22, and less than 5 percent ordered chest radiographs, low-dose spiral computed tomography, and sputum cytology tests, respectively, for asymptomatic patients. In multivariate modeling, physicians who were more likely to have ordered these tests were those who believed that expert groups recommended screening or that screening was effective, those whose usual practice was to recommend screening for asymptomatic patients (including those without substantial smoking exposure), and those whose patients asked about screening.

"Our findings that a majority of reported ordering lung cancer screening tests for asymptomatic patients and that patients have recently asked them about lung cancer screening suggest that ordering of these tests is common among these physicians," the authors write. "At the time of the survey, lung cancer screening was not recommended by major expert groups in the United States."

Explore further: Study finds that annual screening with chest x-ray does not reduce rate of lung cancer deaths

More information: Abstract
Full Text

Related Stories

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.